Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Geske E. Schmidt"'
Autor:
Marcel Werner, Anna Dyas, Iwan Parfentev, Geske E. Schmidt, Iga K. Mieczkowska, Lukas C. Müller-Kirschbaum, Claudia Müller, Stefan Kalkhof, Oliver Reinhardt, Henning Urlaub, Frauke Alves, Julia Gallwas, Evangelos Prokakis, Florian Wegwitz
Publikováno v:
Cell Death and Disease, Vol 13, Iss 9, Pp 1-11 (2022)
Abstract Basal-like breast cancer (BLBC) is a highly aggressive breast cancer subtype frequently associated with poor prognosis. Due to the scarcity of targeted treatment options, conventional cytotoxic chemotherapies frequently remain the standard o
Externí odkaz:
https://doaj.org/article/8323616185d34c74b6e02a3d92901d16
Autor:
Iga K. Mieczkowska, Garyfallia Pantelaiou-Prokaki, Evangelos Prokakis, Geske E. Schmidt, Lukas C. Müller-Kirschbaum, Marcel Werner, Madhobi Sen, Taras Velychko, Katharina Jannasch, Christian Dullin, Joanna Napp, Klaus Pantel, Harriet Wikman, Maria Wiese, Christof M. Kramm, Frauke Alves, Florian Wegwitz
Publikováno v:
Cell Death and Disease, Vol 12, Iss 12, Pp 1-13 (2021)
Abstract Breast cancer (BC) is the most common cancer occurring in women but also rarely develops in men. Recent advances in early diagnosis and development of targeted therapies have greatly improved the survival rate of BC patients. However, the ba
Externí odkaz:
https://doaj.org/article/20c0c3f49a9e491b86d9b16315f3a86d
Autor:
Garyfallia Pantelaiou-Prokaki, Iga Mieczkowska, Geske E. Schmidt, Sonja Fritzsche, Evangelos Prokakis, Julia Gallwas, Florian Wegwitz
Publikováno v:
Clinical Epigenetics
Background Basal-like breast cancer (BLBC) is one of the most aggressive malignant diseases in women with an increased metastatic behavior and poor prognosis compared to other molecular subtypes of breast cancer. Resistance to chemotherapy is the mai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95a9075fe5213340400bd0cd6337fe8b
https://pubmed.ncbi.nlm.nih.gov/35016723
https://pubmed.ncbi.nlm.nih.gov/35016723